J066--Diasorin Molecular MDX | Follow on, Base+4 | Start: 8/1/25

The Department of Veterans Affairs Veterans Health Administration Network Contracting Office 10 in Cincinnati, Ohio has issued a Special Notice for a sole source contract with Diasorin Molecular, Inc. for a Diasorin Molecular MDX service agreement. The contract is intended for the Cincinnati Veterans Affairs Medical Center (VAMC) and will be awarded as a Firm-Fixed Price Contract under FAR Subpart 13.2 procurement guidelines. The service agreement is structured as a base period plus four additional option periods, with contract performance scheduled to commence on August 1, 2025. The notice identifies Diasorin Molecular, Inc., located in Cypress, California, as the intended sole source contractor with UEI number KFFNMC55GHS5. This acquisition falls under the NAICS category for Electronic and Precision Equipment Repair and Maintenance and the PSC category for Maintenance/Repair/Rebuild of Equipment-Instruments and Laboratory Equipment.

The purpose of this Special Notice is to satisfy FAR publication requirements for the proposed sole source contract action while allowing other contractors to submit capabilities statements or quotations for consideration. Contractors interested in responding must submit their materials by July 22, 2025, at 10:00 a.m. Eastern Time to both Michael Groneman, the Contracting Officer, and Andrew Arnst, the Contracting Specialist, via email. The government emphasizes that this notice is not a formal request for quote and no solicitation will be made available. All contractors are eligible to submit capabilities statements or quotations, though the government will not reimburse any costs incurred in preparing responses to this notice. The contract supports laboratory equipment maintenance and repair services for the VA medical facility, ensuring continued operational capability for diagnostic molecular testing equipment.